Hoth Therapeutics, Inc. (HOTH): Nasdaq/NYSE listing notice — Hoth Therapeutics receives Nasdaq deficiency notice for minimum bid price non-compliance

Hoth Therapeutics, Inc.

Nasdaq notified Hoth on April 30, 2026 that bid price closed below $1.00 for 30 consecutive business days (Mar 18 – Apr 29).
Company has 180 calendar days, until October 27, 2026, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not cured by Oct 27, additional 180 days may be granted if company meets other listing requirements.
Company may consider options including a reverse stock split to regain compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Hoth Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 30, 2026, Hoth Therapeutics, Inc. (the “Company”) was notified (the “Notification Letter”) by The Nasdaq Stock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth i

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Hoth Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-051728

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.